Clinical trial
Botox Drug Use Investigation (Spasmodic Dysphonia)
NCT03543150 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Botox Drug Use Investigation (Spasmodic Dysphonia)
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 20, 2018
- Completion date
- February 28, 2022
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.